Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Whit Mayo
LP
Whit Mayo
Wall Street Analyst
★★★☆☆
#1487
on 13Foresight · ranked by our own returns
52%
Success Rate
+14.0%
Average Return
17 of 33 calls profitable · +2.0% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 52% of Whit Mayo's ratings turned a profit when each position was held for 1 year — averaging +14.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

59 Buy 23 Hold 0 Sell
Whit's Stock Coverage 36 ratings · 2026-06-19
Company Date Position Consensus Price Target 1-Yr Return
AIRS
Airsculpt Technologies
May 15, 2026 HOLD Hold
-3.9% avg upside
6 analysts
$4.50
8.99% Downside
+4.8%
ARDT
Ardent Health Partners, Inc.
May 15, 2026 BUY Buy
+52.6% avg upside
16 analysts
$14.00
57.20% Upside
-10.1%
ELV
Elevance Health
Apr 23, 2026 HOLD Strong Buy
+10.8% avg upside
32 analysts
$364.00
6.29% Downside
+12.7%
BTSG
BrightSpring Health Services, Inc.
Mar 02, 2026 BUY Strong Buy
-16.1% avg upside
18 analysts
$49.00
26.02% Downside
+54.9%
UNH
UnitedHealth
Jan 27, 2026 BUY Strong Buy
+2.4% avg upside
35 analysts
$345.00
14.05% Downside
+46.2%
LMRI
Lumexa Imaging Holdings, Inc.
Jan 05, 2026 BUY Strong Buy
+100.8% avg upside
8 analysts
$23.00
144.42% Upside
-53.8%
ACHC
Acadia Healthcare
Dec 03, 2025 HOLD Strong Buy
+57.2% avg upside
17 analysts
$14.00
43.70% Downside
+70.1%
HCA
HCA Healthcare
Oct 22, 2025 BUY Buy
+14.2% avg upside
35 analysts
$465.00
23.88% Upside
-11.6%
CLOV
Clover Health Investments
Oct 22, 2025 HOLD Hold
-29.4% avg upside
9 analysts
$3.00
39.99% Downside
+12.0%
UHS
Universal Health
Oct 22, 2025 BUY Buy
+50.4% avg upside
22 analysts
$276.00
95.44% Upside
-32.6%
THC
Tenet Healthcare
Oct 22, 2025 BUY Strong Buy
+25.2% avg upside
26 analysts
$235.00
36.13% Upside
-13.0%
HUM
Humana
Oct 10, 2025 HOLD Buy
-11.2% avg upside
34 analysts
$273.00
24.40% Downside
+30.3%
MD
Pediatrix Medical Group
Oct 03, 2025 HOLD Buy
-11.2% avg upside
14 analysts
$17.00
27.95% Downside
+34.2%
PRVA
Privia Health Group
Sep 23, 2025 BUY Strong Buy
+34.1% avg upside
26 analysts
$33.00
39.40% Upside
-7.9%
ALHC
Alignment Healthcare
Sep 09, 2025 BUY Strong Buy
+1.8% avg upside
19 analysts
$20.00
8.57% Downside
+19.2%
AHCO
AdaptHealth
Aug 13, 2025 BUY Strong Buy
+48.1% avg upside
12 analysts
$13.00
34.69% Upside
-0.1%
EHC
Encompass Health
Aug 06, 2025 BUY Strong Buy
+13.4% avg upside
22 analysts
$134.00
36.79% Upside
-15.5%
SGRY
Surgery Partners
Aug 06, 2025 BUY Strong Buy
+69.2% avg upside
18 analysts
$34.00
133.69% Upside
-32.4%
AGL
Agilon Health
Aug 05, 2025 HOLD Buy
-59.1% avg upside
26 analysts
$37.50
67.11% Downside
+417.3%
CI
Cigna
Aug 04, 2025 HOLD Strong Buy
+23.8% avg upside
29 analysts
$300.00
7.51% Upside
+9.8%
SVRN
OceanPal Inc
Feb 04, 2025 BUY Strong Buy
6 analysts
·
IP
International Paper Co
Apr 15, 2024 BUY Strong Buy
+25.0% avg upside
20 analysts
+32.4%
NPKI
NPK International
Jan 17, 2024 BUY Buy
+58.6% avg upside
12 analysts
+26.7%
PFS
Provident Financial Services
Apr 06, 2023 BUY Strong Buy
+34.4% avg upside
16 analysts
$76.00
234.59% Upside
-16.8%
OMCL
Omnicell
Mar 29, 2023 HOLD Strong Buy
+36.0% avg upside
12 analysts
$58.00
48.44% Upside
-47.3%
DE:FME
Fresenius Medical Care AG & Co. KGaA
Jul 20, 2021 BUY Buy
+26.9% avg upside
21 analysts
$77.00
89.12% Upside
·
ACAD
ACADIA Pharmaceuticals
Feb 24, 2021 BUY Strong Buy
+66.0% avg upside
42 analysts
$63.00
191.31% Upside
-47.0%
DE:FRE
Fresenius SE & Co. KGaA
Feb 23, 2021 HOLD Strong Buy
+30.0% avg upside
19 analysts
$40.00
0.98% Upside
·
DVA
DaVita
Feb 22, 2021 HOLD Hold
-23.2% avg upside
17 analysts
$106.00
48.99% Downside
+14.1%
CYH
Community Health
Nov 16, 2018 SELL Sell
+44.8% avg upside
18 analysts
$2.00
33.87% Downside
+14.4%
ADUS
Addus Homecare
Mar 13, 2018 HOLD Strong Buy
+35.9% avg upside
18 analysts
$43.00
54.36% Downside
·
SEM
Select Medical
Feb 22, 2018 BUY Buy
+28.1% avg upside
9 analysts
$26.00
57.16% Upside
-15.3%
LH
Labcorp Holdings
Feb 08, 2018 HOLD Strong Buy
+1.8% avg upside
36 analysts
$183.00
28.54% Downside
-12.5%
DGX
Quest Diagnostics
Feb 01, 2018 HOLD Buy
-12.4% avg upside
33 analysts
$106.00
45.67% Downside
-13.6%
FMS
Fresenius Medical Care
Jul 21, 2016 HOLD Buy
+97.5% avg upside
13 analysts
+8.1%
HSTM
HealthStream
Mar 19, 2015 HOLD Buy
+17.0% avg upside
8 analysts
-16.0%
🔒 31 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Whit Mayo — Frequently Asked Questions
How accurate are Whit Mayo's stock ratings?
Based on the calls 13Foresight could measure, about 52% of Whit's ratings were profitable over a one-year hold, with an average return of +14.0% per rating, or +2.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Whit ranked on 13Foresight?
Whit Mayo is currently ranked #1487 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Whit cover?
Whit most recently has ratings on AIRS, ARDT, ELV, BTSG, UNH, LMRI, ACHC, HCA, CLOV, UHS, THC, HUM and 24 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.